entertainment -WSS

entertainment

author：fashion 2025-09-06 03:54:42 - browse：9

Hospital power in DC — Mike Reddy for STAT

WASHINGTON — Democrats unilaterally drove major reforms to the health insurance and the pharmaceutical industries without a single Republican vote in recent years. But hospitals may be a health care giant they’re unable to confront alone.

Unlike Republicans, Democrats have seized on lowering health care costs as a politically winning issue in one election cycle after another. They have campaigned on passing health insurance reform, and then protecting it. And after 20 years, they finally delivered on a promise to empower the federal government to lower drug prices in 2022.

But the remaining elephant in the room is hospital costs, which make up the biggest share of U.S. health care spending. And Democratic leaders in Congress have shown this year that they are unable to agree on even the most incremental steps toward addressing the cost of hospital care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： FTX founder Sam Bankman

knowledge

WSS

UnitedHealth, Optum discontinue NaviHealth name

Health tech investors get more selective as pandemic boom fades

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

The painfully weak evidence on taking collagen to treat arthritis

Questions loom on AstraZeneca cancer drug as safety concerns ebb

In venture capital firm's success, lessons for turning crisis into profit

focus

entertainment

leisure time

In Memoriam: Notable people who died in 2023

FTX founder Sam Bankman

Peter Hotez and the public health issue of online harassment

Sage's campaign to raise awareness of postpartum depression hits a nerve

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

More regulation could be coming for drug ads

Medicare proposal to cover medical devices draws a mixed reaction

Questions loom on AstraZeneca cancer drug as safety concerns ebb

As demand for Covid shots wanes, Moderna seeks its next success

FTX founder Sam Bankman

Wikipedia

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

FDA clears Verve to begin U.S. study of gene

Results on Novartis prostate cancer therapy could expand its use

J&J lung cancer data amount to new salvo against AstraZeneca

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Roche drug slashes death risk in early

focus

knowledge

focus

Wikipedia